New research finds MDMA effective in treating severe PTSD
Mental Health Weekly September 25, 2023 Peer reviewed DOI: 10.1002/mhw.33794
Summary
MDMA-assisted therapy has shown improvement in individuals with severe post-traumatic stress disorder (PTSD). This finding comes from a randomized, placebo-controlled phase 3 trial that assessed the therapy's effects on diverse participants suffering from PTSD. The study was published on September 14 in Nature Medicine.
Study at a glance
| Design | randomized controlled trial |
|---|---|
| Population | individuals suffering from severe post-traumatic stress disorder (PTSD) |
| Key finding | MDMA-assisted therapy resulted in improvement for individuals with severe PTSD. |
Abstract
The third part of a new study assessing MDMA‐assisted therapy, a psychedelic drug also known as Ecstasy, has revealed improvement in diverse individuals suffering with severe post‐traumatic stress disorder (PTSD). The study, “MDMA‐assisted therapy for moderate to severe PTSD: a randomized, placebo‐controlled phase 3 trial,” published Sept. 14 in Nature Medicine.